July 9, 2020 11:12 am ETEstimated Read Time: 3 Minutes
As cannabis reform continues to go global, we are seeing more organizations and reputable statements come out. Now with more than 7000 people working in 150 country offices, the World Health Organization’s (WHO) primary role is to direct and coordinate international health within the United Nations system. They support countries as they coordinate the efforts of governments and partners.
Over the years the WHO has released several statements regarding the use of cannabis. The oldest available scientific report on the WHO website regarding cannabis is from 1971 and even 50 years ago and even then the organization gave clear recommendations of follow up research studies on uses, consumption methods, and effects on human behavior.
WHO Reviews and Changes Cannabis Recommendations
As a follow up to a scientific expert meeting held in 2015 that resulted in the WHO publication, “The health and social effects of nonmedical cannabis use” – WHO hosted a review of the latest available information in the public health of cannabis use and cannabis use disorders in December of 2019
This meeting was organized by the Department of Mental Health and Substance Use in collaboration with other relevant WHO programs. Their intention was updating and revising the above-mentioned publication to reflect the recent developments and accumulated evidence on appropriate public health responses to health risks associated with cannabis use. At the 2019 meeting, experts made a handful of recommendations regarding the scheduling of cannabis (and its resins, preparations, derivatives, etc) in global drug control treaties.
This Would Be The First Reschedule of Cannabis Since 1961
WHO recommendations are often celebrated as a positive step toward the easing of the international control of cannabis. Member states of the United Nations Commission on Narcotic Drugs (CND) received the cannabis recommendations in January 2020 and an expected vote to adopt the changes is scheduled for December 2020.
Apply For Your Medical Marijuana Card Today
Veriheal has satisfied hundreds of thousands of patients nationwide
Get approved or your money back
Appointments available on-demand
Customer support available 24/7
If adopted, this would be the first rescheduling of cannabis since the drafting of the 1961 Single Convention on Narcotics Drugs, a global drug control treaty, so it’s unsurprising that some governments are asking for more time before casting a vote that could catalyze the global cannabis industry.
Other organizations and governmental departments are now beginning to chime in on how, if at all, these recommendations (if adopted) would affect the international control on cannabis both medically and recreationally.
Particularly one recommendation is a big symbolic win because it would implicitly acknowledge the medical value of cannabis at the highest international level. Regarding practical implications in the level of international control, the Vienna-based International Narcotics Control Board (INCB) document found that, if adopted:
Two recommendations would imply no meaningful change.
Two others would mean more control for pure THC.
The other two would imply less control – for certain pharmaceutical preparations containing THC and for some CBD products. But the INCB also said clearer definitions are needed.
Recommendations Are Just That
The 2015 recommendations report specifically states, “…[The expert panel] hope[s] that Member States, institutions, and organizations will be able to make use of this report when prioritizing areas for future international research on the health and social consequences of nonmedical cannabis use.”
While the changes that are being proposed are a sign of progress, they will not have a direct effect on international controls of cannabis. They will however serve as yet another win for the cannabis plant.
Natasha has worked as a journalist in the cannabis scene for several years. She travels regularly in her tiny house school bus conversion to keep up to date with the ever-changing industry. Her experience is varied and eclectic.
Suddenly, the world of magic mushrooms is almost as complicated as that of learning about cannabis. Shrooms or “magic” mushrooms have gained traction as a hallucinogenic therapeutic application for several different mental health circumstances such as depression and migraines—particularly when microdosing. It’s not just liberty caps anymore, folks. There are many different varieties and types…
Edibles are arguably one of the best means of recreational cannabis consumption—you get to eat a treat AND experience a long-lasting high. But it’s easy to end up dealing with some unwanted side effects due to the variability in the onset of these THC-packed goodies, which come in the form of brownies, cookies, gummies, chocolate,…
If you’re reading this, you are either a recreational cannabis veteran who has seen a handful of cannabis smokers passing out from puffing a joint and can’t seem to figure out why. Or, you are a newbie who wants to give recreational or medical cannabis a shot, and the burning question on your mind is,…
According to a new study published by the University of New Mexico (UNM) in the prestigious journal Frontiers in Pharmacology, researchers have unveiled a significant correlation between the sensation of “feeling high” and the relief of medical symptoms among cannabis patients. This landmark study probes uncharted territories, challenging pre-existing assumptions and opening new avenues for…
A survey illustrates psychedelics’ rapid rise, Herer Brands sues Daniel Herer, and Hulkamania comes to cannabis. Let’s dive into this week’s canna-news. Psychedelic Use Reaches Record High A new national survey conducted by Monitoring The Future found that psychedelic use is at an all-time high amongst U.S. adults. Conducted in 2022, the survey included approximately…
We use our own as well as third party cookies to improve your site experience and the services we make available. You can learn more about our use of cookies in our Privacy Policy.
Content Disclamer
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.